| Cell line name |
LUCC1 |
| Accession |
CVCL_W892 |
| Resource Identification Initiative |
To cite this cell line use: LUCC1 (RRID:CVCL_W892) |
| Comments |
Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. |
| Sequence variations |
- Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
|
| Disease |
Recurrent bladder carcinoma (NCIt: C7899) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Sex unspecified |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=19802009; DOI=10.1038/onc.2009.315 Jonathan M. Askham, Fiona M. Platt, Philip A. Chambers, Helen Snowden, Claire F. Taylor, Margaret Anne Knowles; AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Oncogene 29:150-155(2010) PubMed=24367658; DOI=10.1371/journal.pone.0084411; PMCID=PMC3867501 Rebecca L. Ross, Julie E. Burns, Claire F. Taylor, Paul Mellor, Deborah H. Anderson, Margaret Anne Knowles; Identification of mutations in distinct regions of p85 alpha in urothelial cancer. PLoS ONE 8:e84411.1-e84411.11(2013) PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057 Carolyn D. Hurst, Fiona M. Platt, Margaret Anne Knowles; Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur. Urol. 65:367-369(2014) PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350 Tahlita C.M. Zuiverloon, Florus Christiaan de Jong, James C. Costello, Dan Theodorescu; Systematic review: characteristics and preclinical uses of bladder cancer cell lines. Bladder Cancer 4:169-183(2018) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q54903247
|
| Polymorphism and mutation databases |
Cosmic; 1175828
Cosmic; 1286008
Cosmic; 2050449
Cosmic; 2686101
|
| Entry history |
| Entry creation | 17-Jul-2014 |
| Last entry update | 19-Dec-2024 |
| Version number | 10 |
|---|